This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Apria, Inc.(NasdaqGS:APR) dropped from S&P Global BMI Index CI
Apria, Inc.(NasdaqGS:APR) dropped from S&P TMI Index CI
Apria, Inc. Announces Management Changes CI
Apria, Inc.(NasdaqGS:APR) dropped from NASDAQ Composite Index CI
Byram Healthcare Centers, Inc. completed the acquisition of Apria, Inc. from Blackstone Inc. (NYSE:BX), John G. Figueroa and Daniel J. Starck and others. CI
Owens & Minor Prices Upsized $600 Million Placement of 6.625% Notes Due 2030 for Apria Acquisition MT
Owens & Minor to Raise $500 Million via Private Offering of Senior Notes MT
Insider Sell: Apria MT
Apria, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Earnings Flash (APR) APRIA Reports Q4 Revenue $296.5M MT
North American Morning Briefing: All Eyes on -2- DJ
S&P Revises Owens & Minor Outlook To Stable From Positive On Acquisition Of Apria Health, Ratings Affirmed MT
UBS Downgrades Apria to Neutral From Buy, Adjusts Price Target to $37.50 From $41 MT
Top Midday Gainers MT
Owens & Minor Eyes Diversified Revenue Stream With $1.6 Billion Takeover Deal for Healthcare Services Provider Apria MT
Wall Street Set for Lower Open, Tech Rout Drags Nasdaq MT
Health Care Stocks Slip Premarket Monday MT
Health Care MT
Top Premarket Gainers MT
Owens & Minor to buy home healthcare provider Apria for $1.45 bln RE
Owens & Minor to Acquire Apria in $1.6 Billion Deal MT
Owens & Minor to buy Apria for about $1.45 bln RE
Byram Healthcare Centers, Inc. entered into an agreement to acquire Apria, Inc. from Blackstone Inc. (NYSE:BX), John G. Figueroa and Daniel J. Starck and others for $1.4 billion. CI
Certain Common Stock of Apria, Inc. are subject to a Lock-Up Agreement Ending on 9-JAN-2022. CI
Certain Stock Appreciation Rights of Apria, Inc. are subject to a Lock-Up Agreement Ending on 9-JAN-2022. CI
Chart APRIA
More charts
Apria, Inc. is a provider of integrated home healthcare equipment and related services in the United States. The Company offers a range of products and services for in-home care and delivery across three core service lines, which includes home respiratory therapy (including home oxygen and non-invasive ventilation (NIV) services); obstructive sleep apnea (OSA) treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services) and negative pressure wound therapy (NPWT). Additionally, the Company supplies a range of home medical equipment and other products and services for patients with home care needs. It also provides a variety of clinical and administrative support services and related products and supplies. It offers in-home delivery, set-up, and maintenance of equipment and/or supplies; monitoring therapy compliance and intervening to enhance compliance and processing claims to payors on behalf of patients.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. APR Stock
  4. News APRIA
  5. Apria : UBS Adjusts Apria's Price Target to $35 From $32, Maintains Buy Rating